665 related articles for article (PubMed ID: 14695889)
1. Reversing established sepsis with antagonists of endogenous high-mobility group box 1.
Yang H; Ochani M; Li J; Qiang X; Tanovic M; Harris HE; Susarla SM; Ulloa L; Wang H; DiRaimo R; Czura CJ; Wang H; Roth J; Warren HS; Fink MP; Fenton MJ; Andersson U; Tracey KJ
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):296-301. PubMed ID: 14695889
[TBL] [Abstract][Full Text] [Related]
2. Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function.
Tang D; Kang R; Xiao W; Zhang H; Lotze MT; Wang H; Xiao X
Am J Respir Cell Mol Biol; 2009 Dec; 41(6):651-60. PubMed ID: 19265175
[TBL] [Abstract][Full Text] [Related]
3. Anti-high-mobility group box chromosomal protein 1 antibodies improve survival of rats with sepsis.
Suda K; Kitagawa Y; Ozawa S; Saikawa Y; Ueda M; Ebina M; Yamada S; Hashimoto S; Fukata S; Abraham E; Maruyama I; Kitajima M; Ishizaka A
World J Surg; 2006 Sep; 30(9):1755-62. PubMed ID: 16850155
[TBL] [Abstract][Full Text] [Related]
4. Alpha-chemokine receptor blockade reduces high mobility group box 1 protein-induced lung inflammation and injury and improves survival in sepsis.
Lin X; Yang H; Sakuragi T; Hu M; Mantell LL; Hayashi S; Al-Abed Y; Tracey KJ; Ulloa L; Miller EJ
Am J Physiol Lung Cell Mol Physiol; 2005 Oct; 289(4):L583-90. PubMed ID: 15937067
[TBL] [Abstract][Full Text] [Related]
5. Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsis.
Li P; Guo Y; Bledsoe G; Yang ZR; Fan H; Chao L; Chao J
Crit Care; 2015 May; 19(1):200. PubMed ID: 25930108
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptides rescue mice from lethal sepsis by down-regulating secretion of the late-acting inflammatory mediator high mobility group box 1.
Chorny A; Delgado M
Am J Pathol; 2008 May; 172(5):1297-307. PubMed ID: 18385521
[TBL] [Abstract][Full Text] [Related]
7. Effects of adiponectin on mortality and its mechanism in a sepsis mouse model.
Li S; Bao HG; Han L; Liu L; Wang X
J Invest Surg; 2012 Aug; 25(4):214-9. PubMed ID: 22571626
[TBL] [Abstract][Full Text] [Related]
8. Role of high mobility group box 1 in inflammatory disease: focus on sepsis.
Bae JS
Arch Pharm Res; 2012 Sep; 35(9):1511-23. PubMed ID: 23054707
[TBL] [Abstract][Full Text] [Related]
9. Ketamine inhibits LPS-induced HGMB1 release in vitro and in vivo.
Zhang Z; Zhang L; Zhou C; Wu H
Int Immunopharmacol; 2014 Nov; 23(1):14-26. PubMed ID: 25133650
[TBL] [Abstract][Full Text] [Related]
10. Severity of sepsis is correlated with the elevation of serum high-mobility group box 1 in rats.
Hou LC; Qin MZ; Zheng LN; Lu Y; Wang Q; Peng DR; Yu XP; Xin YC; Ji GL; Xiong LZ
Chin Med J (Engl); 2009 Feb; 122(4):449-54. PubMed ID: 19302753
[TBL] [Abstract][Full Text] [Related]
11. Delayed administration of D-Ala2-D-Leu5-enkephalin, a delta-opioid receptor agonist, improves survival in a rat model of sepsis.
Tang CW; Feng WM; Du HM; Bao Y; Zhu M
Tohoku J Exp Med; 2011 May; 224(1):69-76. PubMed ID: 21551984
[TBL] [Abstract][Full Text] [Related]
12. Aloin Reduces HMGB1-Mediated Septic Responses and Improves Survival in Septic Mice by Activation of the SIRT1 and PI3K/Nrf2/HO-1 Signaling Axis.
Yang S; Lee W; Lee BS; Lee C; Park EK; Ku SK; Bae JS
Am J Chin Med; 2019; 47(3):613-633. PubMed ID: 30966773
[TBL] [Abstract][Full Text] [Related]
13. Penehyclidine hydrochloride inhibits the release of high-mobility group box 1 in lipopolysaccharide-activated RAW264.7 cells and cecal ligation and puncture-induced septic mice.
Yang Q; Liu X; Yao Z; Mao S; Wei Q; Chang Y
J Surg Res; 2014 Jan; 186(1):310-7. PubMed ID: 24124976
[TBL] [Abstract][Full Text] [Related]
14. HMGB1 as a potential therapeutic target.
Wang H; Li W; Goldstein R; Tracey KJ; Sama AE
Novartis Found Symp; 2007; 280():73-85; discussion 85-91, 160-4. PubMed ID: 17380789
[TBL] [Abstract][Full Text] [Related]
15. High-mobility group box 1 exacerbates CClâ‚„-induced acute liver injury in mice.
Chen M; Huang W; Wang C; Nie H; Li G; Sun T; Yang F; Zhang Y; Shu K; Wang C; Gong Q
Clin Immunol; 2014 Jul; 153(1):56-63. PubMed ID: 24726765
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic targeting of HMGB1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes.
Stevens NE; Chapman MJ; Fraser CK; Kuchel TR; Hayball JD; Diener KR
Sci Rep; 2017 Jul; 7(1):5850. PubMed ID: 28724977
[TBL] [Abstract][Full Text] [Related]
17. Neutralization of receptor for advanced glycation end-products and high mobility group box-1 attenuates septic diaphragm dysfunction in rats with peritonitis.
Susa Y; Masuda Y; Imaizumi H; Namiki A
Crit Care Med; 2009 Sep; 37(9):2619-24. PubMed ID: 19623040
[TBL] [Abstract][Full Text] [Related]
18. High-mobility-group box protein 1A box reduces development of sodium laurate-induced thromboangiitis obliterans in rats.
Kong X; Yuan H; Wu X; Zhang J; Zhou H; Wang M; Liu Y; Jin X
J Vasc Surg; 2013 Jan; 57(1):194-204. PubMed ID: 23069071
[TBL] [Abstract][Full Text] [Related]
19. HMGB1 mediates cognitive impairment in sepsis survivors.
Chavan SS; Huerta PT; Robbiati S; Valdes-Ferrer SI; Ochani M; Dancho M; Frankfurt M; Volpe BT; Tracey KJ; Diamond B
Mol Med; 2012 Sep; 18(1):930-7. PubMed ID: 22634723
[TBL] [Abstract][Full Text] [Related]
20. [Advances in high mobility group box-1 protein mediated multiple organ dysfunction and its potential interventional strategies].
Yao YM; Xu S; Sheng ZY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Aug; 29(4):459-65. PubMed ID: 19209785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
